These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 3245766
1. Enzymatic reduction of benzamidoxime to benzamidine. Clement B, Schmitt S, Zimmermann M. Arch Pharm (Weinheim); 1988 Dec; 321(12):955-6. PubMed ID: 3245766 [No Abstract] [Full Text] [Related]
2. [The in vitro N-oxygenation of N-tert.alkyl-substituted benzamidine]. Clement B, Immel M. Arch Pharm (Weinheim); 1987 Jul; 320(7):660-5. PubMed ID: 3675161 [No Abstract] [Full Text] [Related]
3. Characteristics of the microsomal N-hydroxylation of benzamidine to benzamidoxime. Clement B, Zimmermann M. Xenobiotica; 1987 Jun; 17(6):659-67. PubMed ID: 3630202 [Abstract] [Full Text] [Related]
4. The N-oxidation of benzamidines in vitro. Clement B. Xenobiotica; 1983 Aug; 13(8):467-73. PubMed ID: 6649680 [Abstract] [Full Text] [Related]
5. [Biotransformation of benzamidine and benzamidoxime by microsomal enzymes of the rabbit]. Clement B, Zimmermann M, Schmitt S. Arch Pharm (Weinheim); 1989 Jul; 322(7):431-5. PubMed ID: 2783015 [Abstract] [Full Text] [Related]
6. [In vitro studies on the microsomal N-oxidation of N-substituted benzamidines]. Clement B. Arch Pharm (Weinheim); 1984 Nov; 317(11):925-33. PubMed ID: 6517675 [No Abstract] [Full Text] [Related]
7. Genotoxic activities of benzamidine and its N-hydroxylated metabolite benzamidoxime in Salmonella typhimurium and mammalian cells. Clement B, Schmezer P, Weber H, Schlehofer JR, Schmitt S, Pool BL. J Cancer Res Clin Oncol; 1988 Nov; 114(4):363-8. PubMed ID: 3045129 [Abstract] [Full Text] [Related]
8. Characterization and partial purification of the rat and human enzyme systems active in the reduction of N-hydroxymelagatran and benzamidoxime. Andersson S, Hofmann Y, Nordling A, Li XQ, Nivelius S, Andersson TB, Ingelman-Sundberg M, Johansson I. Drug Metab Dispos; 2005 Apr; 33(4):570-8. PubMed ID: 15640373 [Abstract] [Full Text] [Related]
9. Biotransformation of benzamidine and benzamidoxime in vivo. Clement B, Immel M, Schmitt S, Steinmann U. Arch Pharm (Weinheim); 1993 Oct; 326(10):807-12. PubMed ID: 8267515 [Abstract] [Full Text] [Related]
10. Phase 2 metabolites of N-hydroxylated amidines (amidoximes): synthesis, in vitro formation by pig hepatocytes, and mutagenicity testing. Clement B, Christiansen K, Girreser U. Chem Res Toxicol; 2001 Mar; 14(3):319-26. PubMed ID: 11258982 [Abstract] [Full Text] [Related]
11. Electrochemical and mARC-catalyzed enzymatic reduction of para-substituted benzamidoximes: consequences for the prodrug concept "amidoximes instead of amidines". Bauch E, Reichmann D, Mendel RR, Bittner F, Manke AM, Kurz P, Girreser U, Havemeyer A, Clement B. ChemMedChem; 2015 Feb; 10(2):360-7. PubMed ID: 25512261 [Abstract] [Full Text] [Related]
12. Hepatic microsomal N-demethylation of N-methylbenzamidine. N-dealkylation vs N-oxygenation of amidines. Clement B, Zimmermann M. Biochem Pharmacol; 1987 Oct 01; 36(19):3127-33. PubMed ID: 3663229 [Abstract] [Full Text] [Related]
13. [The synthesis, analysis, stability and biotransformation of N-(3-methylphenyl)-N'-cyanobenzamidine and analogues (author's transl)]. Pfeifer S, Barnikow G, Schulz M, Kraft R, Fritsche E. Pharmazie; 1981 Nov 01; 36(11):757-63. PubMed ID: 7323123 [Abstract] [Full Text] [Related]
14. Mechanism of the microsomal N-hydroxylation of para-substituted benzamidines. Clement B, Zimmermann M. Biochem Pharmacol; 1988 Dec 15; 37(24):4747-52. PubMed ID: 3202907 [Abstract] [Full Text] [Related]
20. [THE DISTRIBUTION OF N-(4-NITROPHENYL)-BENZAMIDINE-C-14 IN THE ORGANS OF WHITE RATS UNDER CONDITIONS OF ITS USE FOR RADIOPROTECTIVE PURPOSES]. ROBEV S, BAEV I, BONEV L. C R Acad Bulg Sci; 1965 Apr 15; 18():51-4. PubMed ID: 14303433 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]